Cargando…

A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature

The human cytochrome P450 2D6 (CYP2D6) enzyme is part of phase-I metabolism and metabolizes at least 20% of all clinically relevant drugs. Therefore, it is an important target for drug-drug interaction (DDI) studies. High-throughput screening (HTS) assays are commonly used tools to examine DDI, but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hochleitner, Johannes, Akram, Muhammad, Ueberall, Martina, Davis, Rohan A., Waltenberger, Birgit, Stuppner, Hermann, Sturm, Sonja, Ueberall, Florian, Gostner, Johanna M., Schuster, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556109/ https://www.ncbi.nlm.nih.gov/pubmed/28808272 http://dx.doi.org/10.1038/s41598-017-08404-0

Ejemplares similares

Immunomodulatory properties of cacao extracts – potential consequences for medical applications
por: Becker, Kathrin, et al.
Publicado: (2013)

An update on the strategies in multicomponent activity monitoring within the phytopharmaceutical field
por: Gostner, Johanna M, et al.
Publicado: (2012)

Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors
por: Akram, Muhammad, et al.
Publicado: (2017)

Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection
por: Sayer, Michael, et al.
Publicado: (2021)

Computational methods and tools to predict cytochrome P450 metabolism for drug discovery
por: Tyzack, Jonathan D., et al.
Publicado: (2019)

Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids
por: Ueberall, Michael A, et al.
Publicado: (2015)

Discovery and modification of cytochrome P450 for plant natural products biosynthesis
por: Liu, Xiaonan, et al.
Publicado: (2020)

Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations
por: Ueberall, Michael A, et al.
Publicado: (2016)

Effectiveness and Tolerability of Dronabinol Use in Patients with Chronic Pain: A Retrospective Analysis of 12-Week Open-Label Real-World Data Provided by the German Pain e-Registry
por: Ueberall, Michael A, et al.
Publicado: (2022)

Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening
por: Temml, Veronika, et al.
Publicado: (2017)

Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice
por: Ueberall, Michael A, et al.
Publicado: (2016)

Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry
por: Ueberall, Michael A, et al.
Publicado: (2019)

Activation of PKCzeta and PKMzeta in the Nucleus Accumbens Core Is Necessary for the Retrieval, Consolidation and Reconsolidation of Drug Memory
por: Crespo, Jose A., et al.
Publicado: (2012)

The Cytochrome P450 Homepage
por: Nelson, David R
Publicado: (2009)

Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450
por: Campelo, Diana, et al.
Publicado: (2018)

Discovery of a cytochrome P450 enzyme catalyzing the formation of spirooxindole alkaloid scaffold
por: Nguyen, Tuan-Anh M., et al.
Publicado: (2023)

Physicians Experience with and Expectations of the Safety and Tolerability of WHO-Step III Opioids for Chronic (Low) Back Pain: Post Hoc Analysis of Data from a German Cross-Sectional Physician Survey
por: Ueberall, Michael A., et al.
Publicado: (2015)

The FMN “140s Loop” of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450
por: Rwere, Freeborn, et al.
Publicado: (2021)

Fungal cytochrome P450 database
por: Park, Jongsun, et al.
Publicado: (2008)

Cytochrome P450 humanised mice
por: Gonzalez, Frank J
Publicado: (2004)

Intronic polymorphisms of cytochromes P450
por: Ingelman-Sundberg, Magnus, et al.
Publicado: (2010)

The Role of Cytochromes P450 in Infection
por: Stavropoulou, Elisavet, et al.
Publicado: (2018)

Cytochromes P450, Oxygen, and Evolution
por: Lewis, David F.V., et al.
Publicado: (2001)

Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trials
por: Ueberall, Michael A, et al.
Publicado: (2016)

Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine
por: Waltenberger, Birgit, et al.
Publicado: (2011)

Apoptosis induced by the Tibetan herbal remedy PADMA 28 in the T cell-derived lymphocytic leukaemia cell line CEM-C7H2
por: Jenny, Marcel, et al.
Publicado: (2005)

Prediction and analysis of the modular structure of cytochrome P450 monooxygenases
por: Sirim, Demet, et al.
Publicado: (2010)

The Cytochrome P450 Engineering Database: integration of biochemical properties
por: Sirim, Demet, et al.
Publicado: (2009)

Computational Identification of the Paralogs and Orthologs of Human Cytochrome P450 Superfamily and the Implication in Drug Discovery
por: Pan, Shu-Ting, et al.
Publicado: (2016)

Combining HPLC-DAD-QTOF-MS and HPLC-SPE-NMR to Monitor In Vitro Vitetrifolin D Phase I and II Metabolism
por: Sturm, Sonja, et al.
Publicado: (2021)

Correlation of Cytochrome P450 Oxidoreductase Expression with the Expression of 10 Isoforms of Cytochrome P450 in Human Liver
por: Zhang, Hai-Feng, et al.
Publicado: (2016)

1-Aminobenzotriazole: A Mechanism-Based Cytochrome P450 Inhibitor and Probe of Cytochrome P450 Biology
por: de Montellano, Paul R Ortiz
Publicado: (2018)

Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain
por: Burris-Hiday, Sarah D., et al.
Publicado: (2023)

Recombinant production of eukaryotic cytochrome P450s in microbial cell factories
por: Hausjell, Johanna, et al.
Publicado: (2018)

Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2
por: Vuorinen, Anna, et al.
Publicado: (2017)

Comparative Expression Analysis of Cytochrome P450 1A1, Cytochrome P450 1B1 and Nuclear Receptors in the Female Genital and Colorectal Tissues of Human and Pigtailed Macaque
por: Hu, Minlu, et al.
Publicado: (2016)

Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain
por: Ueberall, Michael A, et al.
Publicado: (2016)

Cytochrome P450-Mediated Phytoremediation using Transgenic Plants: A Need for Engineered Cytochrome P450 Enzymes
por: Kumar, Santosh, et al.
Publicado: (2012)

Generation of Complexity in Fungal Terpene Biosynthesis: Discovery of a Multifunctional Cytochrome P450 in the Fumagillin Pathway
por: Lin, Hsiao-Ching, et al.
Publicado: (2014)

Biomarker Discovery for Cytochrome P450 1A2 Activity Assessment in Rats, Based on Metabolomics
por: Pu, Xiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nvg5i0ocm2qtn5uo8pecrirgmv